We are live on
!
Find out more
TCM
Tao Capital Management Portfolio holdings
AUM
$119M
1-Year Est. Return
87.46%
This Fund
S&P 500
This Quarter
Est. Return
-1.82%
1 Year Est. Return
+87.46%
3 Year Est. Return
+356.21%
5 Year Est. Return
+280.73%
10 Year Est. Return
–
AUM
$129M
AUM Growth
-$7.44M
(-5.4%)
Cap. Flow
-$984K
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
99.68%
Holding
14
New
–
Increased
–
Reduced
1
Closed
3
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRNA
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
|
+$802K |
| 2 |
Denali Therapeutics
DNLI
|
+$108K |
| 3 |
BRDS
Bird Global, Inc.
BRDS
|
+$74K |
| 4 |
SOND
Sonder
SOND
|
+$19 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 50.16% |
| 2 | Healthcare | 26.41% |
| 3 | Consumer Discretionary | 22.98% |
| 4 | Consumer Staples | 0.46% |
Similar funds
SF
MWM
VA
HPM
SKK
WKSWA
CA
LC
Tao Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Tao Capital Management held 14 positions worth $129M, down 5.4% from $137M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tao Capital Management's Q3 2023 filing shows 1 reduced and 3 closed positions. The largest sale was GreenLight Biosciences Holdings, PBC Common Stock, an estimated $802K.
By sector, the portfolio is most concentrated in Technology at 50% of assets, up from 45% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Tao Capital Management's biggest Q3 2023 reduction was Sonder, cutting an estimated $19.
- Tao Capital Management fully exited GreenLight Biosciences Holdings, PBC Common Stock in Q3 2023, selling an estimated $802K.
- Tao Capital Management's ten largest holdings make up 100% of its $129M portfolio in Q3 2023.
- Tao Capital Management opened 0 new positions and closed 3 in Q3 2023.
- Tao Capital Management's portfolio value fell 5.4% quarter-over-quarter to $129M.
Based on Tao Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.